Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related macular degeneration (AMD), according to statements from the FDA and the manufacturer.The device allows physicians the opportunity to offer a noninvasive treatment for dry AMD with a low-level laser therapy (LLLT) technology. 1,2

Nov 15, 2024 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.

Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years.

Oct 20, 2024 · As a result, participants in the high-dose gene therapy arm improved from baseline to week 52 by a mean of 0.337±0.0829 logMAR, which is significant compared with those who received sham therapy (P =.0209).. Notably, 76-week gains reached 0.539±0.1032 logMAR, also substantial in comparison with placebo (P =.0014).Patients with low-dose had 52-week progress of 0.382±0.1244 logMAR (P =.0290 ...

Researchers and experts detail the links between ocular conditions and attention deficit hyperactivity disorder, as well as its associated behaviors such as chronic eye rubbing, in both children and adults.

Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...

Dec 4, 2024 · The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. The table below is a review of notable updates that occurred in November 2024 for investigational products in development.

Oct 4, 2024 · Cataract surgeons are responsible for advising patients on a decision that will have lifelong implications. Identifying the intraocular lens (IOL) choice most suited for a particular patient’s lifestyle should be done with the patient’s careful consideration, and full understanding of the portfolio of options before them.

Dec 18, 2024 · As a next step, magnetic resonance imaging (MRI) of the brain with contrast was performed. Restricted diffusion, T2/FLAIR hyperintensity, and gyriform enhancement in the right posterior cerebral arteries (PCA) territory consistent …

Dec 17, 2024 · Systemic methotrexate and azathioprine therapies are associated with a lower risk of proliferative vitreoretinopathy (PVR) development within 6 months of primary retinal detachment, according to the results of a multicenter retrospective cohort study published in Ophthalmology Retina.. PVR is a predominant cause of failure for repair of retinal detachment.